Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD

N. Karoli, A. Rebrov (Russian Federation)

Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Session: COPD: cardiovascular comorbidities
Session type: E-Communication Session
Number: 5205
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Russian Federation). Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5205

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

Evaluation of right atrium remodeling in patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2010 - State of the art imaging
Year: 2010

Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Pulmonary hypertension and right ventricular impairment in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004

Cardiac remodeling and left ventricular-arterial coupling in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015


Pulmonary hypertension and right ventricular impairment in patients with sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Ratio of pulmonary arterial to aortic diameter and right to left ventricular diameter associate with poor outcome in medically-treated chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015

The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001

Echocardiographic indices of right ventricular function in pediatric pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Evaluation of acute right ventricular failure in scleroderma and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Prediction of right ventricular dysfunction in patients with pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 602s
Year: 2007

Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019


Right heart catheterization in elderly patients with suspected pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

Measurement of cardiac troponin identifies patients with moderate to large pulmonary emboli and right ventricular strain
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Right ventricular MRI characteristics in patients with borderline pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Left ventricular systolic torsion is correlated to right ventricular dilation in pulmonary hypertension patients
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015